|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2012)) |
IUPAC Name ![]() |
| ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 6328 | icosapent |
Synonyms ![]() |
| AMR-101 |
| icosapentate |
| Vascepa® |
Database Links ![]() |
|
| CAS Registry No. | 86227-47-6 |
| ChEMBL Ligand | CHEMBL2095209 |
| DrugBank Ligand | DB08887 |
| PubChem CID | 9831415 |
| Search Google for chemical match using the InChIKey | SSQPWTVBQMWLSZ-AAQCHOMXSA-N |
| Search Google for chemicals with the same backbone | SSQPWTVBQMWLSZ |
| Search PubMed clinical trials | icosapent |
| Search PubMed titles | icosapent |
| Search PubMed titles/abstracts | icosapent |
| Wikipedia | Ethyl eicosapentaenoic acid |
| Comments |
| Icosapent is a synthetic derivative of the omega-3 fatty acid eicosapentaenoic acid (EPA). |